ROC曲线分析详细解释

2010-12-19 MedSci原创 MedSci原创

(一)ROC曲线的概念受试者工作特征曲线(receiver operator characteristic curve, ROC曲线),最初用于评价雷达性能,又称为接收者操作特性曲线。ROC曲线是根据一系列不同的二分类方式(分界值或决定阈),以真阳性率(灵敏度)为纵坐标,假阳性率(1-特异度)为横坐标绘制的曲线。传统的诊断试验评价方法有一个共同的特点,必须将试验结果分为两类,再进行统计分析。ROC

(一)ROC曲线的概念受试者工作特征曲线(receiver operator characteristic curve, ROC曲线),最初用于评价雷达性能,又称为接收者操作特性曲线。ROC曲线是根据一系列不同的二分类方式(分界值或决定阈),以真阳性率(灵敏度)为纵坐标,假阳性率(1-特异度)为横坐标绘制的曲线。传统的诊断试验评价方法有一个共同的特点,必须将试验结果分为两类,再进行统计分析。ROC曲线的评价方法与传统的评价方法不同,无须此限制,而是根据实际情况,允许有中间状态,可以把试验结果划分为多个有序分类,如正常、大致正常、可疑、大致异常和异常五个等级再进行统计分析。因此,ROC曲线评价方法适用的范围更为广泛。(二)ROC曲线的主要作用1.ROC曲线能很容易地查出任意界限值时的对疾病的识别能力。2.选择最佳的诊断界限值。ROC曲线越靠近左上角,试验的准确性就越高。最靠近左上角的ROC曲线的点是错误最少的最好阈值,其假阳性和假阴性的总数最少。3.两种或两种以上不同诊断试验对疾病识别能力的比较。在对同一种疾病的两种或两种以上诊断方法进行比较时,可将各试验的ROC曲线绘制到同一坐标中,以

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (29)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2019-03-13 反正

    继续加油

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2017-09-29 susice

    很实用的知识.不错

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2015-11-10 syble

    感谢分享,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2015-04-25 yydlt

    很需要这方面知识!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2015-04-25 yydlt

    最近正在做!

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2012-06-08 zshuai

    thanks for sharing

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2012-05-29 qdchenjg

    能否列出用stata操作ROC的具体步骤,谢谢!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2012-05-28 zhanghengzhu

    很好,需要好好学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2012-05-28 sword01

    能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=362577, encodeId=91d93625e7c4, content=继续加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NfNLvzZhgPxRqgE6xZ8YaH0qaiaLKtuWxbvvEqX8qgSGfkiavaHP6tuo3qpnUefo1gK4oQdnKPjMdSQX6IchZ1ib2s/0, createdBy=317b1661419, createdName=反正, createdTime=Wed Mar 13 14:30:41 CST 2019, time=2019-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=248735, encodeId=0b36248e35da, content=很实用的知识.不错, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20161224/IMG585DA5E26B9F44696.jpg, createdBy=565a98798, createdName=susice, createdTime=Fri Sep 29 08:05:33 CST 2017, time=2017-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=42953, encodeId=e4a542953ef, content=感谢分享,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dc81662331, createdName=syble, createdTime=Tue Nov 10 11:35:00 CST 2015, time=2015-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21968, encodeId=5a3f21968fd, content=很需要这方面知识!, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21967, encodeId=f17a2196e90, content=最近正在做!, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat Apr 25 14:05:00 CST 2015, time=2015-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4365, encodeId=fe74436549, content=thanks for sharing, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af1c36931, createdName=zshuai, createdTime=Fri Jun 08 08:20:00 CST 2012, time=2012-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4321, encodeId=d99f432162, content=能否列出用stata操作ROC的具体步骤,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b8e62098, createdName=qdchenjg, createdTime=Tue May 29 22:03:00 CST 2012, time=2012-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4317, encodeId=ecc2431e6a, content=很好,需要好好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9bf810652, createdName=zhanghengzhu, createdTime=Mon May 28 22:13:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4303, encodeId=31634303d3, content=能否问一下,我看到WJG一篇文章,文中分析了187例胃癌A蛋白表达水平,通过ROC分析后,将187例胃癌分为低,高表达组,我不清楚group中数据如何输入,因为全是胃癌组啊,谢谢!, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c89321222, createdName=sword01, createdTime=Mon May 28 10:08:00 CST 2012, time=2012-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4295, encodeId=ced84295fb, content=很好,有更进一步的理解。, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9a0919575, createdName=jiafufeng, createdTime=Sat May 26 09:12:00 CST 2012, time=2012-05-26, status=1, ipAttribution=)]
    2012-05-26 jiafufeng

    很好,有更进一步的理解。

    0